The Value of Early Cancer Detection
In the first video of this series, PA Sarah Enslin explains why early cancer detection is so critical to successful treatment and outcomes. But while established screening guidelines have significantly reduced cancer deaths, they currently catch only about 1 in 7 cancers overall.
PA Enslin explains the potential role of multi-cancer early detection (MCED) testing, a complement to existing screening protocols that can screen for more than 50 cancer types at once, often before symptoms appear. She outlines who may be an appropriate candidate based on age, personal and family history, and other risk factors.
Key Takeaways:
- Catching cancer early gives us the best chance to treat it successfully.
- Multi-cancer early detection tests screen for over 50 types of cancer.
- One study suggests we could catch over 400,000 more cancers by adding multi-cancer early detection screening for appropriate patients in the United States.
Speaker
Click on the photo below to learn more about the speaker.
References and Additional Resources:
American Institute for Cancer Research. Catching Cancer Early. Published November 13, 2024. Accessed August 3, 2026. https://www.aicr.org/resources/blog/catching-cancer-early/
Cancerguard. Cancerguard FAQ. Accessed August 3, 2026. https://www.cancerguard.com/faq
Galleri. Provider Overview. Accessed August 3, 2026. http://galleri.com/hcp
Hackshaw A, Cohen SS, Reichert H, Kansal AR, Chung KC, Ofman JJ. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK. Br J Cancer. 2021;125(10):1432-1443. https://pmc.ncbi.nlm.nih.gov/articles/PMC8575970/
NORC. Percent of Cancers Detected by Screening. Cancer Detection Tool. Accessed August 3, 2026. https://cancerdetection.norc.org/
Pankind. Early Detection of Pancreatic Cancer. Accessed August 3, 2026. https://pankind.org.au/about-pancreatic-cancer/early-detection/
Supported by
